【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 8
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Candidiasis Overview 11
Therapeutics Development 12
Pipeline Products for Candidiasis – Overview 12
Pipeline Products for Candidiasis – Comparative Analysis 13
Candidiasis – Therapeutics under Development by Companies 14
Candidiasis – Therapeutics under Investigation by Universities/Institutes 17
Candidiasis – Pipeline Products Glance 18
Late Stage Products 18
Clinical Stage Products 19
Early Stage Products 20
Unknown Stage Products 21
Candidiasis – Products under Development by Companies 22
Candidiasis – Products under Investigation by Universities/Institutes 25
Candidiasis – Companies Involved in Therapeutics Development 26
Actavis plc 26
Aureogen Biosciences, Inc. 27
Basilea Pharmaceutica AG 28
Biomar Microbial Technologies 29
Cellceutix Corporation 30
Eisai Co., Ltd. 31
General Biologicals Corporation 32
Grupo Ferrer Internacional, S.A. 33
iCo Therapeutics Inc. 34
Novabiotics Ltd 35
NovaDigm Therapeutics, Inc. 36
Novartis AG 37
Onxeo SA 38
Panacela Labs, Inc. 39
Scynexis, Inc. 40
Sealife PHARMA GMBH 41
Sequella, Inc. 42
Viamet Pharmaceuticals, Inc. 43
Wellstat Vaccines, LLC 44
Candidiasis – Therapeutics Assessment 45
Assessment by Monotherapy Products 45
Assessment by Target 46
Assessment by Mechanism of Action 48
Assessment by Route of Administration 50
Assessment by Molecule Type 52
Drug Profiles 54
AC-17 – Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
albaconazole – Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
amphotericin b – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
arasertaconazole – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
AUGC-10 – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
AUGC-15 – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
candida vaccine – Drug Profile 62
Product Description 62
Mechanism of Action 62
R&D Progress 62
candidiasis vaccine – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
E-1210 – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
E-1211 – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
isavuconazonium sulfate – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
miconazole – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
mutanobactins – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
NDV-3 – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
NDV-3A – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
NP-339 – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
PAC-113 – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
pegylated amphotericin B – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
PEV-7 – Drug Profile 77
Product Description 77
Mechanism of Action 77
R&D Progress 77
PMX-1408 – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
PMX-1502 – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
PMX-1570 – Drug Profile 80
Product Description 80
Mechanism of Action 80
R&D Progress 80
PMX-1576 – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
PMX-1591 – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
PMX-1625 – Drug Profile 83
Product Description 83
Mechanism of Action 83
R&D Progress 83
PMX-30016 – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
PMX-519 – Drug Profile 85
Product Description 85
Mechanism of Action 85
R&D Progress 85
Prof-002 – Drug Profile 86
Product Description 86
Mechanism of Action 86
R&D Progress 86
Recombinant Peptides for Oropharyngeal Candidiasis – Drug Profile 87
Product Description 87
Mechanism of Action 87
R&D Progress 87
SCY-078 – Drug Profile 88
Product Description 88
Mechanism of Action 88
R&D Progress 88
SLP-0901 – Drug Profile 90
Product Description 90
Mechanism of Action 90
R&D Progress 90
SLP-0904 – Drug Profile 91
Product Description 91
Mechanism of Action 91
R&D Progress 91
Small Molecule for Candidiasis – Drug Profile 92
Product Description 92
Mechanism of Action 92
R&D Progress 92
Small Molecule for Candidiasis – Drug Profile 93
Product Description 93
Mechanism of Action 93
R&D Progress 93
Small Molecule for Candidiasis and Cryptococcosis – Drug Profile 94
Product Description 94
Mechanism of Action 94
R&D Progress 94
Small Molecule for Cryptococcosis and Candidiasis – Drug Profile 95
Product Description 95
Mechanism of Action 95
R&D Progress 95
Small Molecule for Fungal Infections – Drug Profile 96
Product Description 96
Mechanism of Action 96
R&D Progress 96
Small Molecules for Aspergillosis and Candidiasis – Drug Profile 97
Product Description 97
Mechanism of Action 97
R&D Progress 97
Small Molecules for Candidiasis – Drug Profile 98
Product Description 98
Mechanism of Action 98
R&D Progress 98
Small Molecules for Candidiasis – Drug Profile 99
Product Description 99
Mechanism of Action 99
R&D Progress 99
Small Molecules for Fungal Infections – Drug Profile 100
Product Description 100
Mechanism of Action 100
R&D Progress 100
SQ-109 – Drug Profile 101
Product Description 101
Mechanism of Action 101
R&D Progress 101
VT-1161 – Drug Profile 104
Product Description 104
Mechanism of Action 104
R&D Progress 104
XELRYX-3 – Drug Profile 106
Product Description 106
Mechanism of Action 106
R&D Progress 106
Candidiasis – Recent Pipeline Updates 108
Candidiasis – Dormant Projects 122
Candidiasis – Discontinued Products 125
Candidiasis – Product Development Milestones 126
Featured News & Press Releases 126
Nov 03, 2014: Basilea Reports Granting Of U.S. Orphan Drug Designation To Isavuconazole For The Treatment Of Invasive Candidiasis 126
Oct 16, 2014: Basilea Reports Protocol Amendment Resulting In Earlier Completion Of Isavuconazole Phase 3 Invasive Candidiasis Study 126
Sep 10, 2014: Data for Viamet’s VT-1161 Presented at ICAAC 2014 127
Jul 16, 2014: FDA Grants Astellas Qualified Infectious Disease Product Designation for Isavuconazole for the Treatment of Invasive Candidiasis 128
Jul 10, 2014: Viamet Reports Additional Positive Interim Results of Phase 2 Study of VT-1161 in Patients with Moderate to Severe Acute Vulvovaginal Candidiasis 128
Apr 01, 2014: BioAlliance Pharma provides an update on its partnerships for Loramyc/Oravig 129
Feb 18, 2014: Viamet Reports Positive Interim Results of Phase 2 Study of VT-1161 130
Nov 18, 2013: Cellceutix Identifies PMX-1408 as treatment Gram-Negative and Candida Fungal Infections 130
Nov 18, 2013: Cellceutix Identifies Drug Candidate for Candida Fungal Infections 131
Sep 26, 2013: NovaDigm Therapeutics Initiates Phase 1b/2a Clinical Trial with NDV-3 Vaccine in Recurrent Vulvovaginal Candidiasis 132
Appendix 134
Methodology 134
Coverage 134
Secondary Research 134
Primary Research 134
Expert Panel Validation 134
Contact Us 135
Disclaimer 135
【レポート販売概要】
■ タイトル：カンジダ症(Candidiasis)の治療薬パイプライン動向（2015年上半期版）■ 英文：Candidiasis - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6028IDB
■ 調査対象地域：グローバル
- 非侵襲性出生前検査（NIPT）の世界市場予測（～2024年）“Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age.”The non-invasive prenatal testing market is projected to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period. Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference …
- 飲食料品用フレキシブル包装の世界市場2018-2022About Flexible Packaging Market for Food and Beverages Flexible packaging finds extensive application in enclosing food and beverage products, irrespective of their size and shape. Flexible packaging is available in the form of pouches, wraps, flexible containers for both primary and secondary applications. Technavio’s analysts forecast the Global Flexible Packaging Market for Food and Beverages t …
- 中国の心臓血管外科用機器市場見通し（～2021）China Cardiovascular Surgery Outlook to 2021 Summary GlobalData’s new report, "China Cardiovascular Surgery Outlook to 2021", provides key procedures data on the China Cardiovascular Surgery. The report provides procedure volumes within market segments - Coronary Artery Bypass Graft (CABG) Procedures and Isolated Valve Procedures. The data in the report is derived from dynamic market forecast mode …
- マグネシウムの世界市場2016-2020About Magnesium Magnesium is the third most abundant metal found in the earth’s crust with a valence of two, and 1s2, 2s2, 2p6, 3s2, 3p6, 3d5, and 4s2 electron configurations. It belongs to 2A group of the periodic table with atomic number 12. It occurs in three isotopes: 24Mg, 25Mg, and 26Mg. Magnesium bonds with other elements very easily and is rarely found in the pure form. Magnesium is found …
- 加速度計およびジャイロスコープ（回転儀）の世界市場予測2022：MEMS型、圧電型、ピエゾ抵抗型The accelerometer and gyroscope market is expected to be worth USD 3.50 Billion by 2022. The high-end accelerometer and gyroscope market is expected to grow at a CAGR of 3.8% between 2016 and 2022, to reach USD 2.07 Billion by 2022 from USD 1.59 Billion in 2015. The high-end accelerometer and gyroscope market is majorly driven by the increasing defense expenditure globally, whereas the overall mar …
- ULD（ユニットロードデバイス）の世界市場予測（～2021年）The unit load device market is projected to grow from USD 1.64 Billion in 2016 to USD 2.02 Billion by 2021, at a CAGR of 4.28% during the forecast period. Various factors, such as increase in demand for lightweight ULDs, growth in international trade, and increase in demand for cold containers are expected to drive the unit load device market. The market is segmented on the basis of product type, …
- eコマース（電子商取引）ソフトウェアおよびサービス投資の世界市場About E-commerce Software and Services Spending Electronic commerce, commonly called e-commerce, refers to the process of buying and selling products and services over computer networks. With the changing business landscape worldwide, several industries such as traditional retailers, banks, and travel agents have been aggressively embracing e-commerce technology, which can help them operate throug …
- 浴室付属品の世界市場：流通経路別、地域別Global Bathroom Accessories Market: About this market Technavio’s bathroom accessories market analysis considers sales from both offline and online distribution channels. Our study also finds the sales of bathroom accessories in APAC, Europe, MEA, North America, and South America. In 2019, the offline segment had a significant market share, and this trend is expected to continue over the forecast …
- 先端相変化材料の世界市場：有機相変化材料、無機相変化材料、バイオ相変化材料About phase change materials Phase change materials are products that release or absorb heat when they change from one phase to another (usually from solid to liquid or vice versa). These materials store thermal energy in the form of latent heat, which is released when they freeze or crystallize and absorbed when they melt at their respective melting/freezing temperature points. Hence, they are us …
- Venous Thromboembolism：グローバル臨床試験レビューH1, 2013Venous Thromboembolism Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H1, 2013" provides data on the Venous Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous Thromboembolism . It includes an overview of the trial numbers an …
- MDI（ジフェニルメタンジイソシアネート）の世界市場2015-2019About MDI MDIs (methylene diphenyl diisocyanates) are fundamentally utilized as crude materials for PUs, which are the most adaptable polymers that exist in myriad structures going from rigid foams to dense solid compositions and from flexible foams to elastomers. PUs occur in two structures: PU foams and PU non-foams. Rigid PU foams are mostly utilized as insulators in construction, industrial, p …
- 世界のベントナイト市場：市場規模、動向、メーカー動向Scope The report presents a thorough study of bentonite, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing bentonite production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: bentonite p …
- コンベヤーモニタリングの世界市場展望2017-2026According to Stratistics MRC, the Global Conveyor Monitoring market accounted for $ 193.16 million in 2017 and is expected to reach $ 312.75 million by 2026 growing at a CAGR of 5.5% during the forecast period. Some of the key factors such rising focus of companies on reducing revenue loss due to faults in conveyor belts and motors and increasing adoption of analytical tools and techniques are boo …
- 世界の半導体装備市場分析：Analyzing the Global Semiconductor Equipment MarketThe global market for semiconductor equipments has been growing at a rapid pace since 2006. With Asia Pacific leading the global market in terms of market value, the wafer processing segment remained the market's most lucrative in 2011. The segment accounted for nearly 80% of the global market value. The semiconductor equipment market is highly concentrated, and the share of the largest manufactur …
- フィルター付きウォーターボトルの世界市場2019-2023Global Water Bottles with Filters Market: About this market Water bottles with filters are primarily used by individuals while traveling, camping, and backpacking. It is also commonly used by military personnel. Technavio’s water bottles with filters market analysis consider sales through the offline and online distribution channel segments. Our analysis also considers the sales of water bottles w …
